Researchers at St. Jude Children’s Research Hospital tirelessly and brilliantly work to advance cures for, and prevent, pediatric catastrophic diseases through research and treatment; and in their work they make discoveries beyond our core mission.
These discoveries require further development, so our office endeavors to license them to companies who will turn them into successful products. Here are just a few examples of discoveries licensed from St. Jude that have been incorporated into products or processes that are now deployed in the marketplace.
Xalkori® is now being tested in pediatric cancers, such as neuroblastoma and Anaplastic large cell lymphoma (ALCL), the population where the ALK gene was first discovered, bringing the discovery full circle: Crizotinib targets ALK-driven cancers in pediatric trial
